Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the extent to which the Voluntary Scheme for Branded Medicines Pricing Access (VPAS) has met its objectives as laid out in the scheme documentation of supporting the life sciences industry across the UK and future innovation; and if will make a statement.

The Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) has met the objectives laid out in the scheme documentation, as discussed at the mid-scheme review held in September 2021.

The minutes of the review are available at the following link:

https://www.gov.uk/government/publications/2019-voluntary-scheme-for-branded-medicines-pricing-and-access-operational-review-and-mid-scheme-review-minutes-28-september-2021/28-september-2021-minutes